Vaxcyte Inc expected to post a loss of 98 cents a share - Earnings Preview

Vaxcyte

02/08/2024 14:36

* Vaxcyte Inc  PCVX.OQ   PCVX.O  is expected to show no
change in
quarterly revenue when it reports  results on August 6
(estimated) for the period ending June 30 2024
    * 
    * ​LSEG's mean analyst estimate for Vaxcyte Inc is for a
loss
of 98 cents per share. 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 10 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Vaxcyte Inc
is
$101.00​, above​ its last closing price of $78.59. ​​​

This summary was machine generated August 2 at 13:36 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)